When the treatment with anti-Fas antibody was compared to either mock or pSV treatment, there was an evident decrease in the phosphorylation of JNK with the specific blocking of Fas activation which showed the Fas-mediated JNK activation in these glioma xenograft cells (Fig. 7C). Here, FAS is linked to glioma.